Barricaid
Manufacturing · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
30 Commerce Way, Woburn, Massachusetts, ...Phone Number
(781) 932-0222Website
www.barricaid.comRevenue
$25.1 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Barricaid
Intrinsic Therapeutics is a medical device company focused on delivering a safe treatment to improve efficacy in patients who are at a disproportionately high risk of requiring repeat surgeries due to reherniation following a lumbar discectomy surgery. The Barricaid bone-anchored annular closure device received FDA PMA-approval following completion of a 554-patient randomized controlled trial that achieved superiority at two years. Survival analyses have indicated statistical significance in reducing reherniations and reoperations through five years.Explore more
Barricaid Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Barricaid your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Barricaid has new funding data
Congratulate Masked Content for being promoted to Masked Content at Barricaid
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Barricaid, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Barricaid had a recent Job posting/layoffs
Product Launch: Get notified when Barricaid launches new products
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Barricaid recently announced quarterly report
Check if Barricaid has recently received funding, and reach out quickly before it becomes old news!
Check out if Barricaid is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Barricaid as Masked Content
Find more new buyers
Compare Similar Companies to Barricaid
Compare insights from companies similar to Barricaid, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Barricaid is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Barricaid is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Barricaid.
Barricaid Tech Stack
A closer look at the technologies used by Barricaid
Most Recent Scoops
Event
Product Marketing, Events, Sales, Search, Doctors / Physicians, Medical Research, Field /Outside Sales, Field Marketing, Healthcare Operations, Healthcare Technology, Operations
Event
Product Marketing, Events, Sales, Search, Doctors / Physicians, Medical Research, Field /Outside Sales, Field Marketing, Healthcare Operations, Healthcare Technology, Operations
New Hire
Executive Move
Executive Moves, New Hire, Board of Directors
New Hire
Executive Move
Executive Moves, New Hire, Board of Directors
Left Company
Executive Move
Executive Moves, Left Company
Barricaid News & Media
Intrinsic Therapeutics Announces the First Endoscopic Barricaid Implantation in the Great Lakes Region by Dr. Nick Nenadovich
BOSTON, Nov. 14, 2025 /PRNewswire/ -- Intrinsic Therapeutics, Inc., the makers of the Barricaid® Bone-Anchored Annular Closure Device, announced today the first endoscopic Barricaid implantation in the Great Lakes Region was completed by Nick Nenadovich, MD, a University of Chicago...Intrinsic Therapeutics Announces that AMA Released CPT 2026 Code Set Including New CPT Code 63032 Describing Bone-Anchored Annular Closure, Effective January 1, 2026
BOSTON, Oct. 24, 2025 /PRNewswire/ -- Intrinsic Therapeutics, Inc., the makers of the Barricaid® Annular Closure Device, announced today that the American Medical Association (AMA) has published a new Category I CPT® code, 63032, for bone-anchored annular closure, effective January 1,...Intrinsic Therapeutics Announces the First Implantation of the Barricaid® Annular Closure Device Under Awake Sedation
BOSTON, Sept. 2, 2025 /PRNewswire/ -- Intrinsic Therapeutics, Inc., a medical technology company committed to redefining the standard of care for lumbar discectomy patients with large annular defects by reducing reoperations for reherniations by 81%* with its Barricaid Annular Closure...Intrinsic Therapeutics Appoints Industry Veterans Mike Lytle and Dave Decker to Lead Sales and Advance Discectomy Treatment
BOSTON, Aug. 18, 2025 /PRNewswire/ -- Intrinsic Therapeutics, Inc., a medical technology company committed to redefining the standard of care for lumbar discectomy patients with large annular defects by reducing reoperations for reherniations by 81%* with its Barricaid Annular Closure...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Barricaid
Sign Up For FreeTo access detailed company insights
Intrinsic Therapeutics is a medical device company focused on delivering a safe treatment to improve efficacy in patients who are at a disproportionately high risk of requiring repeat surgeries due to reherniation following a lumbar discectomy surgery. The Barricaid bone-anchored annular closure device received FDA PMA-approval following completion... Read More
